GWEN RATHBUN

SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.

SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.

SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.

SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.

SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.

SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley) H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. (Lobbyist used: Gwen Rathbun, Deema Tarazi) S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program. (Lobbyist used: Gwen Rathbun, Contract Lobbyists)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP) and provisions lowering prescription drug costs, which ADA supports. ADA does not weigh in on other aspects of the legislation. Issues worked on not yet reflected in legislation: FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley) H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. (Lobbyist used: Gwen Rathbun, Deema Tarazi) S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program. (Lobbyist used: Gwen Rathbun, Contract Lobbyists)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley) H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. (Lobbyist used: Gwen Rathbun, Deema Tarazi) S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program. (Lobbyist used: Gwen Rathbun, Contract Lobbyists)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP) and provisions lowering prescription drug costs, which ADA supports. ADA does not weigh in on other aspects of the legislation. Issues worked on not yet reflected in legislation: FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley) H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. (Lobbyist used: Gwen Rathbun, Deema Tarazi) S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program. (Lobbyist used: Gwen Rathbun, Contract Lobbyists)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP) and provisions lowering prescription drug costs, which ADA supports. ADA does not weigh in on other aspects of the legislation. Issues worked on not yet reflected in legislation: FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP) and provisions lowering prescription drug costs, which ADA supports. ADA does not weigh in on other aspects of the legislation. Issues worked on not yet reflected in legislation: FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP) and provisions lowering prescription drug costs, which ADA supports. ADA does not weigh in on other aspects of the legislation. Issues worked on not yet reflected in legislation: FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley) H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. (Lobbyist used: Gwen Rathbun, Deema Tarazi) S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program. (Lobbyist used: Gwen Rathbun, Contract Lobbyists)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. Issues worked on not yet reflected in legislation: 2019 reauthorization of the Special Diabetes Program (SDP). The Association supports renewal of both components of SDP. FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program. FY 2020 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies.

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP) and provisions lowering prescription drug costs, which ADA supports. ADA does not weigh in on other aspects of the legislation. Issues worked on not yet reflected in legislation: FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley) H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. (Lobbyist used: Gwen Rathbun, Deema Tarazi) S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program. (Lobbyist used: Gwen Rathbun, Contract Lobbyists)

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley) H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. (Lobbyists used: Gwen Rathbun, Meghan Riley, Deema Tarazi) H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. (Lobbyist used: Gwen Rathbun, Deema Tarazi) S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program. (Lobbyist used: Gwen Rathbun, Contract Lobbyists)

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

S. 192, Community and Public Health Programs Extension Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), which ADA supports. ADA does not weigh in on other aspects of the legislation. H.R. 2668, the Special Diabetes Program Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for type 1 diabetes for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2680, the Special Diabetes Programs for Indians Reauthorization Act of 2019. Reauthorizes the Special Diabetes Program for Indians for fiscal years 2020 - 2024 for $200 million per year. Support legislation. H.R. 2740, FY 2020 House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R.3163/S.2520, FY 2020 House Transportation-HUD Appropriations. ADA supports inclusion of language to direct FAA to disclose the number of pilots with insulin-dependent diabetes who have been issued licenses. S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. H.R. 2328, the Reauthorizing and Extending Americas Community Health Act/REACH Act. Includes 4-year reauthorization of the Special Diabetes Program. ADA does not weigh in on other aspects of the legislation. S. 2474, FY 2020 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program.

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program (Lobbyist used: Contract Lobbyists) BUD H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun) BUD H.R. 1892, Continuing Resolution through March 23/Spending Caps Deal. Support parts of bill, including reauthorization of the Special Diabetes Program through September 2019. (Lobbyist used: Meghan Riley, Gwen Rathbun, Rob Goldsmith) BUD H.R. 1625, Consolidated Appropriations Act, 2018. Support parts of the bill which increased funding for diabetes research and programs at the National Institute of Diabetes and Digestive and Kidney Diseases, CDCs Division of Diabetes Translation, and through the National Diabetes Prevention Program. (Lobbyists used: Meghan Riley, Gwen Rathbun, and Rob Goldsmith) BUD Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program. (Lobbyist used: Contract Lobbyists) BUD 4.) Federal Agencies/ Branches Contacted HCR and BUD U.S. House of Representatives U.S. Senate Department Health and Human Services: -Centers for Disease Control and Prevention, Division of Diabetes Translation -National Institutes of Health (NIDDK) -Centers for Medicare and Medicaid Services -Federal and Drug Administration

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program (Lobbyist used: Contract Lobbyists) BUD H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun) BUD H.R. 1892, Continuing Resolution through March 23/Spending Caps Deal. Support parts of bill, including reauthorization of the Special Diabetes Program through September 2019. (Lobbyist used: Meghan Riley, Gwen Rathbun, Rob Goldsmith) BUD H.R. 1625, Consolidated Appropriations Act, 2018. Support parts of the bill which increased funding for diabetes research and programs at the National Institute of Diabetes and Digestive and Kidney Diseases, CDCs Division of Diabetes Translation, and through the National Diabetes Prevention Program. (Lobbyists used: Meghan Riley, Gwen Rathbun, and Rob Goldsmith) BUD Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program. (Lobbyist used: Contract Lobbyists) BUD 4.) Federal Agencies/ Branches Contacted HCR and BUD U.S. House of Representatives U.S. Senate Department Health and Human Services: -Centers for Disease Control and Prevention, Division of Diabetes Translation -National Institutes of Health (NIDDK) -Centers for Medicare and Medicaid Services -Federal and Drug Administration

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) HR 5952, Senate bill (not numbered). National Defense Authorization Act for FY 2019. Oppose provisions that would limit the Congressionally Directed Medical Research Program. FY 2019 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R. 2, Agriculture and Nutrition Act of 2018. House Farm Bill; oppose parts of the bill which could lead to 5 to 7 million Americans losing SNAP benefits. S. 3042, Agriculture Improvement Act of 2018. Senate Farm Bill; support parts of bill which reauthorizes SNAP without changing the structure of the program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2, Agriculture and Nutrition Act of 2018. House Farm Bill; oppose parts of the bill which could lead to 5 to 7 million Americans losing SNAP benefits. S. 3042, Agriculture Improvement Act of 2018. Senate Farm Bill; support parts of bill which reauthorizes SNAP without changing the structure of the program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 6157, FY 2019 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R. 2, Agriculture and Nutrition Act of 2018. House Farm Bill; oppose parts of the bill which could lead to 5 to 7 million Americans losing SNAP benefits. S. 3042, Agriculture Improvement Act of 2018. Senate Farm Bill; support parts of bill which reauthorizes SNAP without changing the structure of the program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 4978/S. 2410, the Chronic Disease Management Act. ADA supports this legislation which would allow HSA eligible high deductible health plans to provide beneficiary coverage of chronic disease management care before reaching their deductible limit. H.R. 5768, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM).

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. (Lobbyist used: Meghan Riley) HCR H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; oppose the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. (Lobbyists used: Meghan Riley, Gwen Rathbun) HCR The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. (Lobbyists used: Meghan Riley, Rob Goldsmith) HCR Issues worked on not yet reflected in legislation: Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. (Lobbyists used: Meghan Riley, Robert Goldsmith) HCR Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) HCR Gestational Diabetes Act of 2018. Support past legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program (Lobbyist used: Contract Lobbyists) BUD H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun) BUD H.R. 1892, Continuing Resolution through March 23/Spending Caps Deal. Support parts of bill, including reauthorization of the Special Diabetes Program through September 2019. (Lobbyist used: Meghan Riley, Gwen Rathbun, Rob Goldsmith) BUD H.R. 1625, Consolidated Appropriations Act, 2018. Support parts of the bill which increased funding for diabetes research and programs at the National Institute of Diabetes and Digestive and Kidney Diseases, CDCs Division of Diabetes Translation, and through the National Diabetes Prevention Program. (Lobbyists used: Meghan Riley, Gwen Rathbun, and Rob Goldsmith) BUD Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program. (Lobbyist used: Contract Lobbyists) BUD 4.) Federal Agencies/ Branches Contacted HCR and BUD U.S. House of Representatives U.S. Senate Department Health and Human Services: -Centers for Disease Control and Prevention, Division of Diabetes Translation -National Institutes of Health (NIDDK) -Centers for Medicare and Medicaid Services -Federal and Drug Administration

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program (Lobbyist used: Contract Lobbyists) BUD H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun) BUD H.R. 1892, Continuing Resolution through March 23/Spending Caps Deal. Support parts of bill, including reauthorization of the Special Diabetes Program through September 2019. (Lobbyist used: Meghan Riley, Gwen Rathbun, Rob Goldsmith) BUD H.R. 1625, Consolidated Appropriations Act, 2018. Support parts of the bill which increased funding for diabetes research and programs at the National Institute of Diabetes and Digestive and Kidney Diseases, CDCs Division of Diabetes Translation, and through the National Diabetes Prevention Program. (Lobbyists used: Meghan Riley, Gwen Rathbun, and Rob Goldsmith) BUD Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program. (Lobbyist used: Contract Lobbyists) BUD 4.) Federal Agencies/ Branches Contacted HCR and BUD U.S. House of Representatives U.S. Senate Department Health and Human Services: -Centers for Disease Control and Prevention, Division of Diabetes Translation -National Institutes of Health (NIDDK) -Centers for Medicare and Medicaid Services -Federal and Drug Administration

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. (Lobbyist used: Meghan Riley) HCR H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; oppose the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. (Lobbyists used: Meghan Riley, Gwen Rathbun) HCR The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. (Lobbyists used: Meghan Riley, Rob Goldsmith) HCR Issues worked on not yet reflected in legislation: Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. (Lobbyists used: Meghan Riley, Robert Goldsmith) HCR Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) HCR Gestational Diabetes Act of 2018. Support past legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 4978/S. 2410, the Chronic Disease Management Act. ADA supports this legislation which would allow HSA eligible high deductible health plans to provide beneficiary coverage of chronic disease management care before reaching their deductible limit. H.R. 5768, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 4978/S. 2410, the Chronic Disease Management Act. ADA supports this legislation which would allow HSA eligible high deductible health plans to provide beneficiary coverage of chronic disease management care before reaching their deductible limit. H.R. 5768, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM).

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM).

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 4978/S. 2410, the Chronic Disease Management Act. ADA supports this legislation which would allow HSA eligible high deductible health plans to provide beneficiary coverage of chronic disease management care before reaching their deductible limit. H.R. 5768, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM). S.3592, the No More Surprise Medical Bills Act of 2018. At the request of Senator Maggie Hassans office, the Association provided feedback on this legislation which seeks to help people avoid paying large and unnecessary medical bills.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) HR 5952, Senate bill (not numbered). National Defense Authorization Act for FY 2019. Oppose provisions that would limit the Congressionally Directed Medical Research Program. FY 2019 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R. 2, Agriculture and Nutrition Act of 2018. House Farm Bill; oppose parts of the bill which could lead to 5 to 7 million Americans losing SNAP benefits. S. 3042, Agriculture Improvement Act of 2018. Senate Farm Bill; support parts of bill which reauthorizes SNAP without changing the structure of the program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program (Lobbyist used: Contract Lobbyists) BUD H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun) BUD H.R. 1892, Continuing Resolution through March 23/Spending Caps Deal. Support parts of bill, including reauthorization of the Special Diabetes Program through September 2019. (Lobbyist used: Meghan Riley, Gwen Rathbun, Rob Goldsmith) BUD H.R. 1625, Consolidated Appropriations Act, 2018. Support parts of the bill which increased funding for diabetes research and programs at the National Institute of Diabetes and Digestive and Kidney Diseases, CDCs Division of Diabetes Translation, and through the National Diabetes Prevention Program. (Lobbyists used: Meghan Riley, Gwen Rathbun, and Rob Goldsmith) BUD Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program. (Lobbyist used: Contract Lobbyists) BUD 4.) Federal Agencies/ Branches Contacted HCR and BUD U.S. House of Representatives U.S. Senate Department Health and Human Services: -Centers for Disease Control and Prevention, Division of Diabetes Translation -National Institutes of Health (NIDDK) -Centers for Medicare and Medicaid Services -Federal and Drug Administration

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 6157, FY 2019 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R. 2, Agriculture and Nutrition Act of 2018. House Farm Bill; oppose parts of the bill which could lead to 5 to 7 million Americans losing SNAP benefits. S. 3042, Agriculture Improvement Act of 2018. Senate Farm Bill; support parts of bill which reauthorizes SNAP without changing the structure of the program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program (Lobbyist used: Contract Lobbyists) BUD H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Gwen Rathbun) BUD H.R. 1892, Continuing Resolution through March 23/Spending Caps Deal. Support parts of bill, including reauthorization of the Special Diabetes Program through September 2019. (Lobbyist used: Meghan Riley, Gwen Rathbun, Rob Goldsmith) BUD H.R. 1625, Consolidated Appropriations Act, 2018. Support parts of the bill which increased funding for diabetes research and programs at the National Institute of Diabetes and Digestive and Kidney Diseases, CDCs Division of Diabetes Translation, and through the National Diabetes Prevention Program. (Lobbyists used: Meghan Riley, Gwen Rathbun, and Rob Goldsmith) BUD Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program. (Lobbyist used: Contract Lobbyists) BUD 4.) Federal Agencies/ Branches Contacted HCR and BUD U.S. House of Representatives U.S. Senate Department Health and Human Services: -Centers for Disease Control and Prevention, Division of Diabetes Translation -National Institutes of Health (NIDDK) -Centers for Medicare and Medicaid Services -Federal and Drug Administration

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 4978/S. 2410, the Chronic Disease Management Act. ADA supports this legislation which would allow HSA eligible high deductible health plans to provide beneficiary coverage of chronic disease management care before reaching their deductible limit. H.R. 5768, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM).

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM). S.3592, the No More Surprise Medical Bills Act of 2018. At the request of Senator Maggie Hassans office, the Association provided feedback on this legislation which seeks to help people avoid paying large and unnecessary medical bills.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2, Agriculture and Nutrition Act of 2018. House Farm Bill; oppose parts of the bill which could lead to 5 to 7 million Americans losing SNAP benefits. S. 3042, Agriculture Improvement Act of 2018. Senate Farm Bill; support parts of bill which reauthorizes SNAP without changing the structure of the program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) HR 5952, Senate bill (not numbered). National Defense Authorization Act for FY 2019. Oppose provisions that would limit the Congressionally Directed Medical Research Program. FY 2019 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R. 2, Agriculture and Nutrition Act of 2018. House Farm Bill; oppose parts of the bill which could lead to 5 to 7 million Americans losing SNAP benefits. S. 3042, Agriculture Improvement Act of 2018. Senate Farm Bill; support parts of bill which reauthorizes SNAP without changing the structure of the program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 6157, FY 2019 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. H.R. 2, Agriculture and Nutrition Act of 2018. House Farm Bill; oppose parts of the bill which could lead to 5 to 7 million Americans losing SNAP benefits. S. 3042, Agriculture Improvement Act of 2018. Senate Farm Bill; support parts of bill which reauthorizes SNAP without changing the structure of the program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 5423, Gestational Diabetes Act of 2018. Support legislation which aims to reduce incidences of gestational diabetes and improve outcomes for people with gestational diabetes. H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM).

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM). S.3592, the No More Surprise Medical Bills Act of 2018. At the request of Senator Maggie Hassans office, the Association provided feedback on this legislation which seeks to help people avoid paying large and unnecessary medical bills.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) H.R. 5768/S. 3366, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. S. 2554, the Patient Right to Know Drug Prices Act. The Association supports this legislation which would prohibit pharmacy gag clauses in contracts between a pharmacy and an insurer or pharmacy benefit manager (PBM). S.3592, the No More Surprise Medical Bills Act of 2018. At the request of Senator Maggie Hassans office, the Association provided feedback on this legislation which seeks to help people avoid paying large and unnecessary medical bills.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts. H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases. H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan. H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA. The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. Issues worked on not yet reflected in legislation: Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization. Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts. H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases. H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan. H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA. The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. Issues worked on not yet reflected in legislation: Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization. Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts. H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases. H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan. H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA. The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. Issues worked on not yet reflected in legislation: Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization. Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts. H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases. H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan. H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA. The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. Issues worked on not yet reflected in legislation: Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization. Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts. H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases. H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan. H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA. The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. Issues worked on not yet reflected in legislation: Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization. Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts. H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases. H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan. H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA. The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. Issues worked on not yet reflected in legislation: Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization. Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. Issues worked on not yet reflected in legislation: Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program.

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts. H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases. H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan. H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA. The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. Issues worked on not yet reflected in legislation: Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization. Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR

1 and 2.) Federal Legislation and Issues (H.R. designates work with House of Representatives; S. designates work with Senate) S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts. H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases. H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities. H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan. H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund. H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA. The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market. Issues worked on not yet reflected in legislation: Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization. Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients. Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR